Why insider trading matters?

What separates FormWhispers.com from others is that we created it to meet our own needs and we use it everyday to make better investment decisions. We will keep improving it to serve us better and to serve you better.

- Founders of FormWhispers.com
Arcutis Biotherapeutics, Inc. (ARQT)
Sector: Healthcare; Industry: Biotechnology

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company is also developing ARQ-154, a topical foam formulation of ARQ-151 for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical small molecule inhibitor of janus kinase type 1 for hand eczema and other inflammatory dermatoses; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin to the postulated site of inflammation in alopecia areata. Arcutis Biotherapeutics, Inc. was founded in 2016 and is headquartered in Westlake Village, California.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-10-02 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 496,000 $25.00 $12,400,000 No
2020-10-02 SILVERSTEIN JONATHAN 10%-Owner, Director Buy 496,000 $25.00 $12,400,000 No
2020-10-01 Welgus Howard G. Director Sell 2,200 $27.65 $60,829 Yes
2020-09-01 Welgus Howard G. Director Sell 2,200 $24.38 $53,643 Yes
2020-09-29 Watanabe Todd Franklin President and CEO Sell 3,000 $30.00 $90,000 Yes
2020-09-29 OSBORNE DAVID W Chief Technical Officer Sell 15,000 $30.00 $450,000 No
2020-09-29 Smither John W Chief Financial Officer Sell 1,750 $30.00 $52,500 Yes
2020-09-01 Welgus Howard G. Director Sell 2,200 $24.38 $53,643 Yes
2020-08-03 Welgus Howard G. Director Sell 2,800 $25.63 $71,764 Yes
2020-02-04 Bain Capital Life Sciences Investors, LLC 10%-Owner Buy 294,117 $17.00 $4,999,989 Yes
2020-02-04 Heron Patrick J 10%-Owner, Director Buy 500,000 $17.00 $8,500,000 Yes
2020-02-04 Frazier Life Sciences VIII, L.P. 10%-Owner Buy 500,000 $17.00 $8,500,000 Yes
2020-02-03 ORBIMED ADVISORS LLC 10%-Owner, Director Buy 558,888 $17.00 $9,501,096 Yes
2020-02-03 SILVERSTEIN JONATHAN 10%-Owner, Director Buy 558,888 $17.00 $9,501,096 Yes

Insider Smart

Enphase Energy, Inc (ENPH) - Watch for CEO Kothandaraman Badrinarayanan and CFO Branderiz Eric, their trading have a good pattern you can't miss, very well timed buy low and sell high.

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.